As of 2025-09-18, the Relative Valuation of TCR2 Therapeutics Inc (TCRR) is (54.73) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.48 USD, the upside of TCR2 Therapeutics Inc based on Relative Valuation is -3798.0%.
The range of the Relative Valuation is (53.09) - (56.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 13.6x | 13.2x |
| Forward P/E multiples | 12.8x - 13.5x | 13.2x |
| Fair Price | (53.09) - (56.25) | (54.73) |
| Upside | -3687.2% - -3900.5% | -3798.0% |
| Date | P/E |